| Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI N Galldiks, KJ Langen, R Holy, M Pinkawa, G Stoffels, KW Nolte, ... Journal of Nuclear Medicine 53 (7), 1048-1057, 2012 | 211 | 2012 |
| pO2-Polarographie versus Positronenemissionstomographie ([18F]-Fluormisonidazol, [18F]-Fluordeoxyglucose). Eine Bewertung der strahlentherapeutisch … B Gagel, P Reinartz, E DiMartino, M Zimny, M Pinkawa, P Maneschi, ... Strahlentherapie und Onkologie 180, 616-622, 2004 | 167 | 2004 |
| Prognostic value of early [18F] fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme MD Piroth, M Pinkawa, R Holy, J Klotz, S Nussen, G Stoffels, HH Coenen, ... International Journal of Radiation Oncology* Biology* Physics 80 (1), 176-184, 2011 | 157 | 2011 |
| Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer R Holy, M Piroth, M Pinkawa, MJ Eble Strahlentherapie und Onkologie 187 (4), 245, 2011 | 157 | 2011 |
| A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer … DY Song, KK Herfarth, M Uhl, MJ Eble, M Pinkawa, B Van Triest, ... International Journal of Radiation Oncology* Biology* Physics 87 (1), 81-87, 2013 | 154 | 2013 |
| [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung … B Gagel, P Reinartz, C Demirel, HJ Kaiser, M Zimny, M Piroth, M Pinkawa, ... BMC cancer 6, 1-8, 2006 | 142 | 2006 |
| Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas MD Piroth, M Pinkawa, R Holy, J Klotz, S Schaar, G Stoffels, N Galldiks, ... Strahlentherapie und Onkologie 188 (4), 334, 2012 | 139 | 2012 |
| Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer M Pinkawa, NE Corral, M Caffaro, MD Piroth, R Holy, V Djukic, G Otto, ... Radiotherapy and Oncology 100 (3), 436-441, 2011 | 134 | 2011 |
| Application technique: placement of a prostate–rectum spacer in men undergoing prostate radiation therapy G Hatiboglu, M Pinkawa, JP Vallée, B Hadaschik, M Hohenfellner BJU international 110 (11b), E647-E652, 2012 | 126 | 2012 |
| Prostate position variability and dose–volume histograms in radiotherapy for prostate cancer with full and empty bladder M Pinkawa, B Asadpour, B Gagel, MD Piroth, R Holy, MJ Eble International Journal of Radiation Oncology* Biology* Physics 64 (3), 856-861, 2006 | 118 | 2006 |
| An overlap‐volume‐histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection Y Yang, EC Ford, B Wu, M Pinkawa, B Van Triest, P Campbell, DY Song, ... Medical physics 40 (1), 011709, 2013 | 108 | 2013 |
| Erectile dysfunction after external beam radiotherapy for prostate cancer M Pinkawa, B Gagel, MD Piroth, K Fischedick, B Asadpour, M Kehl, ... European urology 55 (1), 227-236, 2009 | 106 | 2009 |
| Prognostic impact of postoperative, pre-irradiation 18F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy MD Piroth, R Holy, M Pinkawa, G Stoffels, HJ Kaiser, N Galldiks, H Herzog, ... Radiotherapy and Oncology 99 (2), 218-224, 2011 | 98 | 2011 |
| pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography … B Gagel, M Piroth, M Pinkawa, P Reinartz, M Zimny, HJ Kaiser, S Stanzel, ... BMC cancer 7, 1-9, 2007 | 97 | 2007 |
| Dose-escalation using intensity-modulated radiotherapy for prostate cancer–evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous … M Pinkawa, C Attieh, MD Piroth, R Holy, S Nussen, J Klotz, R Hawickhorst, ... Radiotherapy and Oncology 93 (2), 213-219, 2009 | 91 | 2009 |
| Dose-intensified versus conventional-dose salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: the SAKK 09/10 randomized phase 3 trial P Ghadjar, S Hayoz, J Bernhard, DR Zwahlen, T Hölscher, P Gut, B Polat, ... European urology 80 (3), 306-315, 2021 | 88 | 2021 |
| Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial M Uhl, K Herfarth, MJ Eble, M Pinkawa, B van Triest, R Kalisvaart, ... Radiation Oncology 9, 1-6, 2014 | 85 | 2014 |
| Image-guided radiotherapy for prostate cancer M Pinkawa, M Pursch-Lee, B Asadpour, B Gagel, MD Piroth, J Klotz, ... Strahlentherapie und Onkologie 184 (12), 679, 2008 | 81 | 2008 |
| Spacer stability and prostate position variability during radiotherapy for prostate cancer applying a hydrogel to protect the rectal wall M Pinkawa, MD Piroth, R Holy, N Escobar-Corral, M Caffaro, V Djukic, ... Radiotherapy and Oncology 106 (2), 220-224, 2013 | 80 | 2013 |
| Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme-a dosimetric comparison MD Piroth, M Pinkawa, R Holy, G Stoffels, C Demirel, C Attieh, HJ Kaiser, ... Radiation Oncology 4, 1-12, 2009 | 80 | 2009 |
Karl-Josef LangenVerified email at fz-juelich.de
